A Study of Anti-PD-L1 Antibody ZKAB001 Combined With Albumin-bound Paclitaxel in Advanced Urothelial Carcinoma

NCT04603846 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Urothelial Carcinoma

Interventions

DRUG: anti-PD-L1 antibody
DRUG: albumin bound paclitaxel

Sponsor

Lee's Pharmaceutical Limited